<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">22728351</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>10</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1420-3049</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2012</Year>
                        <Month>May</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecules (Basel, Switzerland)</Title>
                <ISOAbbreviation>Molecules</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of diversified methods for chemical modification of the 5,6-double bond of uracil derivatives depending on active methylene compounds.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6519-46</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules17066519</ELocationID>
            <Abstract>
                <AbstractText>The reaction of 5-halogenouracil and uridine derivatives 1 and 7 with active methylene compounds under basic conditions produced diverse and selective C-C bond formation products by virtue of the nature of the carbanions. Three different types of reactions such as the regioselective C-C bond formation at the 5- and 6-positions of uracil and uridine derivatives (products 2, 5, 8, 17, 20 and 21), and the formation of fused heterocycle derivatives 2,4-diazabicyclo[4.1.0]heptane (15) and 2,4-diazabicyclo-[4.1.0]nonane (16) via dual C-C bond formations at both the 5- and 6-positions were due to the different active methylene compounds used as reagents.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sajiki</LastName>
                    <ForeName>Hironao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Organic Chemistry, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan. sajiki@gifu-pu.ac.jp</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iida</LastName>
                    <ForeName>Yusuke</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ikawa</LastName>
                    <ForeName>Kanoko</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sawama</LastName>
                    <ForeName>Yoshinari</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monguchi</LastName>
                    <ForeName>Yasunari</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kitade</LastName>
                    <ForeName>Yukio</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maki</LastName>
                    <ForeName>Yoshifumi</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inoue</LastName>
                    <ForeName>Hideo</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirota</LastName>
                    <ForeName>Kosaku</ForeName>
                    <Initials>K</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2012</Year>
                <Month>05</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Molecules</MedlineTA>
            <NlmUniqueID>100964009</NlmUniqueID>
            <ISSNLinking>1420-3049</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>56HH86ZVCT</RegistryNumber>
                <NameOfSubstance UI="D014498">Uracil</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>WHI7HQ7H85</RegistryNumber>
                <NameOfSubstance UI="D014529">Uridine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D014498" MajorTopicYN="N">Uracil</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014529" MajorTopicYN="N">Uridine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>04</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2012</Year>
                <Month>05</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>05</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2012</Year>
                <Month>6</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2012</Year>
                <Month>6</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">22728351</ArticleId>
            <ArticleId IdType="pii">molecules17066519</ArticleId>
            <ArticleId IdType="doi">10.3390/molecules17066519</ArticleId>
            <ArticleId IdType="pmc">PMC6269048</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Pharm Bull (Tokyo). 2007 May;55(5):837-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17473483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Pharmacother. 1996 Sep;30(9):967-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8876858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Chem Soc. 1975 Sep 17;97(19):5572-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1159236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Chem Soc. 1977 Jun 22;99(13):4534-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">864127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chem Rev. 2003 May;103(5):1875-916</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12744695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 1996 Feb 2;39(3):789-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8576922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry. 1973 Sep 25;12(20):3992-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4745658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chemistry. 2000 Jun 16;6(12):2200-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10926226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 1999 Nov 4;42(22):4479-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10579812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Chem Soc. 1975 Sep 17;97(19):5566-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1159235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2000 Dec 28;43(26):4993-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11150169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Org Chem. 1975 Feb 7;40(3):353-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1133618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Biotechnol. 2000 Sep;1(2):137-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11467334</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>